Literature DB >> 7698704

Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis.

D Mutimer1, J Shaw, J Neuberger, S Skidmore, B Martin, S Hubscher, P McMaster, E Elias.   

Abstract

Sporadic non-A, non-B hepatitis is the most common indication for liver transplantation in patients presenting with fulminant and subacute liver failure. This study used serological, histological, and molecular biological techniques to examine specimens from 23 consecutive patients transplanted for sporadic non-A, non-B hepatitis. No evidence was found of hepatitis C virus, hepatitis E virus, or 'cryptic' hepatitis B virus infection.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7698704      PMCID： PMC1382460          DOI： 10.1136/gut.36.3.433

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  28 in total

1.  Chronic hepatitis in liver allografts.

Authors:  S G Hubscher
Journal:  Hepatology       Date:  1990-11       Impact factor: 17.425

2.  Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis.

Authors:  M Omata; T Ehata; O Yokosuka; K Hosoda; M Ohto
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

3.  Heterotopic liver transplantation for fulminant hepatic failure--a bridge to recovery.

Authors:  M J Moritz; B E Jarrell; V Armenti; J Radomski; R A Carabasi; G Zeitoun; K Columbus; R Rubin; S Munoz; W Maddrey
Journal:  Transplantation       Date:  1990-09       Impact factor: 4.939

4.  Enhanced detection by PCR of hepatitis C virus RNA.

Authors:  J A Garson; C Ring; P Tuke; R S Tedder
Journal:  Lancet       Date:  1990-10-06       Impact factor: 79.321

5.  Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease.

Authors:  S Todo; A J Demetris; D Van Thiel; L Teperman; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

6.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

7.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.

Authors:  M J Alter; S C Hadler; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; L A Moyer; H A Fields; D W Bradley
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

8.  Hepatitis B virus and hepatitis D virus replication in HBsAg-positive fulminant hepatitis.

Authors:  A Mas; M Buti; R Esteban; J M Sánchez-Tapias; J Costa; R Jardí; M Bruguera; J Guardia; J Rodés
Journal:  Hepatology       Date:  1990-06       Impact factor: 17.425

9.  Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.

Authors:  S E Davies; B C Portmann; J G O'Grady; P M Aldis; K Chaggar; G J Alexander; R Williams
Journal:  Hepatology       Date:  1991-01       Impact factor: 17.425

10.  Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

Authors:  A J Weiner; G Kuo; D W Bradley; F Bonino; G Saracco; C Lee; J Rosenblatt; Q L Choo; M Houghton
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321
View more
  1 in total

Review 1.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.